ABI
SGEN

Adamant Biomedical Investments’s Seagen Inc. Common Stock SGEN Stock Holding History

Adamant Biomedical Investments’s Portfolio SGEN Stock Details SGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$1.28M Hold
40,000
– – 0.31% 77
2014
Q3 		$1.49M Buy
+40,000
New +$1.57M 0.37% 70

Other funds holding SGEN

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CGT
Capital Guardian Trust Los Angeles, California $7.42B AUM 13.6% 1-Year Est. Return

Adamant Biomedical Investments's SGEN Position: Q4 2014 in Review

Adamant Biomedical Investments held its Seagen Inc. Common Stock (SGEN) position steady in Q4 2014 at 40,000 shares worth $1.28M. The position accounts for 0.31% of the portfolio, ranked #77.

Adamant Biomedical Investments first reported a position in SGEN in Q3 2014 and has held it in 2 quarters since. The position peaked at $1.49M in Q3 2014. 214 funds tracked by Wall St. Rank hold SGEN as of Q4 2014.

  • Adamant Biomedical Investments held 40,000 shares of Seagen Inc. Common Stock worth $1.28M as of Q4 2014.
  • Adamant Biomedical Investments left its Seagen Inc. Common Stock share count unchanged in Q4 2014.
  • Seagen Inc. Common Stock made up 0.31% of Adamant Biomedical Investments's portfolio in Q4 2014, its #77 holding.
  • Adamant Biomedical Investments first reported a position in Seagen Inc. Common Stock in Q3 2014 and has held it in 2 quarters since.
  • Adamant Biomedical Investments's Seagen Inc. Common Stock position peaked at $1.49M in Q3 2014.
  • 214 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.